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ABSTRACT 
Rapid advance in sequencing technology has led to genome-wide analysis of genetic and 
epigenetic features simultaneously, making it possible to understand the biological mechanisms 
underlying cancer initiation and progression. However, how to identify important prognostic 
features poses a great challenge for both statistical modeling and computing. In this thesis, a 
network-based approach is applied to the Cancer Genome Atlas (TCGA) ovarian cancer data to 
identify important genes related to the overall survival of ovarian cancer patients. In the first 
step, a stepwise correlation-based selector is used to reduce the dimensionality of TCGA data, by 
filtering out a large number of unrelated genes. Second, we employ the graphical lasso to 
construct a sparse gene-gene co-expression network. The undirected network allows us to 
classify genes into groups based on gene-gene interaction. We fit a cox proportional hazard 
model with a sparse group lasso penalty for further variable selection and identify 232 genes, 
which are prognostic for ovarian cancer survival. Of these 232 genes, many were reported to be 
associated with cancer initiation or progression in the literature. The Kaplan-Meier curves based 
on the identified genes show clear separation among different groups of patients based on 
different gene expression levels.   
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1.  INTRODUCTION  
Ovarian cancer is one of the most common gynecologic cancers, ranking fifth as the 
cause for cancer-related deaths among women in the United States. According to The American 
Cancer Society, it is estimated that about 22, 280 women will receive a new diagnosis of ovarian 
cancer and about 14, 240 women will die from it in 2016. About 70% of most deaths occur in 
patients with advanced-stage, high-grade serous ovarian cancer.  
The standard treatment for these patients is usually surgery, followed by platinum-taxane 
chemotherapy. Platinum-resistant cancer often recurs within six months in about 25% of patients 
and there is an overall five-year survival probability of 31%. Approximately 13% of high-grade 
serous ovarian cancer can be attributed to germline mutations in BRCA1 and BRCA2 and a 
smaller percentage can be accounted for by other germline mutations (The Cancer Genome Atlas 
Research Network [8]).  
Due to the rapid advances in next-generation sequencing technology, it is now possible to 
simultaneougly perform genome-wide analysis of genetic and epigenetic features (Zhang et al. 
[47]). The Cancer Genome Atlas (TCGA) project provides the most extensive genomic data 
resource for more than 30 types of cancers (http://cancergenome.nih.gov/). For instance, the 
ovarian cancer data from the TCGA contain both clinical and molecular profiles from 586 tumor 
samples. The clinical profile includes records on recurrence, survival, and treatment resistance. 
The molecular profile includes copy number variation (CNV), DNA methylation, exon 
expression, gene expression (microarray), gene expression (RNA-seq), genotype (SNP), 
MicroRNA expression (microarray), MicroRNA-seq, protein expression, and somatic mutation. 
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These high-dimensionality datasets have motivated the study of molecular mechanisms of cancer 
through computational approaches.  
     A crucial step in the construction of a regression model when there are tens of 
thousands of features present in the dataset is feature selection. The purpose of feature selection 
is to select a subset of the original features so that the feature space is optimally reduced based 
on a certain evaluation criterion. As the years progress, the dimensionality of data keeps 
increasing in both the number of instances as well as the number of features in various 
applications. This high-dimensionality leads to problems such as scalability and learning 
performance of many machine learning algorithms. For instance, high-dimensional data such as a 
gene expression dataset with hundreds or thousands of genes can have large amount of irrelevant 
and redundant features which may significantly reduce the performance of machine learning 
algorithms. Through feature selection, we are able to remove irrelevant or redundant features 
which increases computational efficiency and estimation accuracy. 
  Feature selection algorithms are divided into two categories which include the filter 
model and the wrapper model. Using the filter model, certain features are selected based on 
general characteristics of the training data without the use of any learning algorithm. On the 
other hand, the wrapper model uses the performance of a predetermined learning algorithm to 
evaluate and select the features. The wrapper model has a superior learning performance than the 
filter model since it selects features which are more suited to the predetermined learning 
algorithm; however, it tends to be more computationally expensive than the filer model. So, the 
filter model is often preferred due to its computational efficiency when dealing with a large 
number of features.  
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Zhang et al. [49] proposed a novel stepwise correlation-based selector (SCBS) which 
imitates the hierarchy of the Bayesian network model for feature selection. This approach was 
applied to the TCGA ovarian cancer data and several interesting results were obtained which 
provided insight on the genetic/epigenetic mechanisms of ovarian cancer.   
In this paper, we identify biomarkers which play a crucial role in the overall survival of 
the ovarian cancer patients. The data we are going to analyze is the ovarian cancer data, which 
was retrieved from the TCGA portal. The ovarian cancer data from TCGA includes 586 samples 
with gene expression profiles containing level 3 UNC Agilent G4502A_07 microarrays. The data 
contains gene expression level for 17,814 genes. Due to the high-dimensionality of the data, we 
use the stepwise correlation-based selector (SCBS) proposed by Zhang et al. [49] and select a 
subset of 603 genes from the 17, 814 genes. With these 603 genes, we will construct an 
undirected network using the graphical lasso model proposed by Friedman et al. [11]. This will 
allow for the identification of gene clusters, which will be used in fitting a cox proportional 
hazard model using a sparse group lasso penalty (Friedman et al. [12]).  
The rest of paper is organized as follows: in Chapter 2, we provide some background 
information through the revision of papers based on the sparse inverse covariance estimation 
with the graphical lasso and sparse group lasso. In Chapter 3, we study statistical methods such 
as the stepwise correlation-based selector, graphical lasso, cox proportional hazard model with 
sparse group lasso penalty, and Kaplan-Meier curves. In Chapter 4, we interpret the results 
obtained from the analysis. Conclusions are given in Chapter 5. 
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2.  BACKGROUND/LITERATURE REVIEW 
2.1  Sparse inverse covariance estimation with the graphical lasso 
Several authors have proposed the method of 𝑙1 (lasso) regularization as a form of 
estimating sparse undirected graphical models. The underlying assumption for this basic model 
is that the observations follow a multivariate Gaussian distribution with mean 𝜇 and covariance 
matrix Σ. Given other variables, variables 𝑖 and 𝑗 are said to be conditionally independent if the 
𝑖𝑗𝑡ℎcomponent of Σ−1 is zero. For this reason, an 𝑙1 penalty is imposed when estimating Σ
−1 
under sparsity assumption.  
Different methods for the optimization of the exact log-likelihood have been proposed by 
several researchers (Yuan and Lin [46]; Banerjee et al. [3]; Friedman et al. [11]). Given 𝑛 
multivariate normal observations of dimension 𝑝, with mean 𝜇 and covariance matrix Σ, we want 
to maximize the penalized log-likelihood 
 
 l(Θ) = log |Θ| − 𝑡𝑟(𝑆Θ) − 𝜆‖Θ‖1 ( 2.1.1) 
 
where 𝑆 represents the sample covariance matrix, Θ = Σ−1, and ‖Θ‖1 = ∑ |Θij|𝑖,𝑗 . 
 According to Banerjee et al. [3], the maximization of equation (2.1.1) is equivalent to 
solving the dual problem  
 
 min
𝛽
{
1
2
‖𝑊11
1
2 𝛽 − 𝑊11
−
1
2𝑠12‖
2
+ 𝜆‖𝛽‖1} ( 2.1.2) 
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where  
 𝑊 = [
𝑊11 𝑤12
𝑤12
𝑇 𝑤22
] ( 2.1.3) 
 𝑆 = [
𝑆11 𝑠12
𝑠12
𝑇 𝑠22
] ( 2.1.4) 
 
 Suppose we let 𝛽 = 𝑊11
−1𝑤12, then the problem becomes much easier due to the 
equivalence between (2.1.1) and (2.1.2). This lasso problem can be solved using a coordinate 
descent procedure. Friedman et al. [13] developed a simple algorithm known as the graphical 
lasso, which is extremely fast. This algorithm is able to solve a 1000-node problem within a 
minute and is 3000 times faster than other competing algorithms. The graphical lasso algorithm 
can be implemented as follows: 
  
Since the graphical lasso algorithm is simple and fast in estimating a sparse inverse 
covariance matrix using the 𝑙1 penalty, it should aid in the application of sparse inverse 
covariance procedures involving large datasets, which contain thousands of parameters.  
Step 3
Continue until 𝑊 converges. 
Step 2
Solve the lasso problem in (2.1.2) and estimate  𝛽. Replace 𝑤12 = 𝑊11  𝛽.
Step 1
Compute 𝑊 = 𝑆 + 𝜆𝐼
6 
 
2.2  A sparse-group lasso 
For problems where there are grouped covariates, which can have sparse effects on a 
group as well as within group level, a regularized model for linear regression is introduced with 
𝑙1 and 𝑙2 penalties. Let us begin by examining the usual linear regression model. We have a 
dataset which consists of an 𝑛 response vector 𝑦, and an 𝑛 by 𝑝 matrix of features, 𝑋. In recent 
times, we have been presented with applications in which 𝑝 ≫ 𝑛. For such applications, standard 
regression fails. To overcome this problem, Tibshirani [41] developed the lasso approach, which 
regularizes the problem by bounding the 𝑙1 norm of the solution. The lasso approach minimizes  
 
 
1
2
‖𝑦 − 𝑋𝛽‖2 + 𝜆‖𝛽‖1 ( 2.2.1) 
 
and computes a solution with a small number of nonzero entries in 𝛽. Suppose our data contains 
predictor variables which are divided into 𝑚 different groups. An example of this is gene 
expression data which may contain groups for gene pathways or factor level indicators in 
categorical data.  
The objective is to find a solution which uses only a few of the groups, in addition to 
achieving sparsity in 𝛽. To solve this problem, Yuan and Lin [46] proposed the group lasso 
criterion. The problem is as follows 
 
 min
𝛽
1
2
‖𝑦 − ∑ 𝑋(𝑙)𝛽(𝑙)
𝑚
𝑙=1
‖
2
+ 𝜆 ∑ √𝑝𝑙‖𝛽
(𝑙)‖
𝑚
𝑙=1
 ( 2.2.2) 
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where 𝑋(𝑙) is a submatrix of 𝑋 with columns corresponding to the predictors in group 𝑙, 𝛽(𝑙) is 
the coefficient vector corresponding to that group and 𝑝𝑙 is the length of 𝛽
(𝑙). The magnitude of 
the tuning parameter 𝜆 determines the sparsity of the solution. Note that if each group size is 1, 
the result is a regular lasso solution.  
 The group lasso model yields a sparse set of groups; however, the presence of a group in 
the model results in all nonzero coefficients in the group. Suppose we want to achieve both 
sparsity of groups and within each group. To do this, we use the sparse group lasso, which uses 
the formula  
 
 min
𝛽
1
2𝑛
‖𝑦 − ∑ 𝑋(𝑙)𝛽(𝑙)
𝑚
𝑙=1
‖
2
+ (1 − 𝛼)𝜆 ∑ √𝑝𝑙‖𝛽
(𝑙)‖ + 𝛼
𝑚
𝑙=1
𝜆‖𝛽‖1 ( 2.2.1) 
 
where 𝛼 ∈ [0,1]. The mixing parameter, 𝛼, is a convex combination of the lasso and group lasso 
penalties since 𝛼 = 0 produces a group lasso fit and  𝛼 = 1 produces a lasso fit.  
 The sparse group lasso model is often used for regression problems involving categorical 
predictors. For predictors with a large number of levels, many of the levels for the predictors 
included are sometimes not very informative so the sparse group lasso accounts for this by 
replacing the coefficients with zero for many levels even in the nonzero groups. The sparse 
group lasso is sometimes useful for analyzing gene expression data as it is able to find interesting 
pathways from which driving genes are selected. In addition, the model also reduces the 
estimated effects of driving genes within a group toward one another (Simon et al. [34]).  
 For comparison purposes, all three models (sparse group lasso, group lasso, and lasso) 
were applied on two real data examples involving gene expression data, the colitis data and 
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breast cancer data. In the colitis data, the lasso outperformed the group lasso and the sparse 
group lasso while in the breast cancer data, the sparse group lasso outperformed the lasso and 
group lasso. The difference in these results is due to the fact that group information in the cancer 
data is critical for classification and the grouping provides us with insights into the biological 
mechanisms while the group information in the colitis data simply increases model variance. 
Although the sparse group lasso may not be applicable to all grouped data, it can sometimes be 
useful as in the case of the cancer data.       
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3.  METHODOLOGY 
3.1  Feature Selection 
As the years progress, the dimensionality of data keeps increasing in both the number of 
instances as well as the number of features in various applications. This high-dimensionality 
leads to problems such as scalability and learning performance of many machine learning 
algorithms. For instance, high-dimensional data such as the TCGA ovarian cancer data with 
17,814 genes can have a large number of irrelevant and redundant genes, which may 
significantly reduce the performance of machine learning algorithms. As the dimensionality of a 
dataset increases, there is an increasing difficulty in proving the result statistically significant due 
to the sparsity of the meaningful data in the dataset in question. With an increase in 
dimensionality also comes an increase in computational cost which is usually exponentially. To 
overcome this problem we use feature selection methods to reduce the number of features in 
consideration.  
Feature selection is a very essential requirement when dealing with high-dimensional 
data so that data overfitting is avoided and further analysis is possible. Feature selection 
algorithms are divided into two categories which include the filter model and the wrapper model. 
Using the filter model, certain features are selected based on general characteristics of the 
training data without the use of any learning algorithm. On the other hand, the wrapper model 
uses the performance of a predetermined learning algorithm to evaluate and select the features. 
The wrapper model has a superior learning performance than the filter model since it selects 
features which are more suited to the predetermined learning algorithm; however, it tends to be 
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more computationally expensive than the filer model. So, the filter model is often preferred due 
to its computational efficiency when dealing with a large number of features.  
In this paper, the feature selection method that is applied to the TCGA ovarian cancer 
data is a stepwise correlation-based selector (SCBS). The underlying assumption we make from 
a biological perspective is that cancer phenotype is directly associated with gene expression. The 
17,814 genes from our TCGA ovarian cancer data are fed into the stepwise correlation-based 
selector (SCBS) and the selection process begins. We begin by computing the correlation 
between the genes and survival time. At this step, we detect those genes which are significantly 
correlated with survival time and these genes are selected to be a part of our subset. In the next 
step, we select those genes which are correlated with the genes that were selected in the first 
step. We continue in this manner of progressively selecting genes that correlate with the selected 
genes until a subset with the desired number of genes is obtained. Using this stepwise 
correlation-based selector, we select 603 genes from the total 17,814 genes. The SCBS algorithm 
can be implemented as follows: 
 
 
Step 1
Compute the 
correlation 
coefficients between 
the current node 𝑋𝑖
and all the other 
nodes. 
Keep the 𝑘 highest 
correlated nodes with 
𝑋𝑖 for additional 
filtering. 
Step 2
Compute the 𝑝-value 
of the correlation 
coefficient for each of 
the 𝑘 nodes selected in 
step 1. 
If the 𝑝-value is 
significant under the 
Benjamini-Hochberg 
procedure with 
𝐹𝐷𝑅 ≤ 0.05, the node 
is selected.    
Step 3
Repeat step 1 and 2 
until 𝑝 nodes are 
selected.   
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The correlation coefficients are computed using Pearson’s correlation method. To perform the 
hypothesis test, the correlations are transformed using Fisher’s z-transformation, which is a 
function of 𝑟 whose sampling distribution of the transformed value is close to normal. Fisher’s z-
transformation is given by 
 
 𝑍 =
1
2
ln (
1 + 𝑟
1 − 𝑟
) ( 3.2.1) 
 
where 𝑟 is the sample correlation, 𝑍 is the transformed value of 𝑟, and ln is the natural logarithm. 
Using the fact that 𝑍 approximately follows a standard normal distribution, 𝑍~𝑁(0,1), we 
compute the p-values of the correlation coefficients. Note that in the implementation of the 
SCBS algorithm, 𝑘 is set to four. The value of 𝑘 is selected based on previous studies which 
suggest that 𝑘 should be four, five, or six. A small value of 𝑘 fails to capture weakly connected 
nodes and a large value of 𝑘 tends to capture more false positives.  
 When compared to single-round filtering methods, the stepwise correlation-based selector 
appears to be more effective in selecting those with features, which are associated with the 
phenotype-related pathways but are indirectly associated with the cancer phenotype. To better 
understand this, let us consider the following scenario. Assume there is a casual relationship such 
as 𝐴 → 𝐵 → 𝐶𝑎𝑛𝑐𝑒𝑟. Although there is a strong correlation between 𝐴 and 𝐵 or 𝐵 and cancer, 
the correlation between 𝐴 and cancer could decay significantly to the extent of being 
undetectable.          
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3.2  Graphical Lasso 
Recently, the estimation of the inverse covariance in a high-dimensional setting where 
the number of features 𝑝 is greater than the number of observations 𝑛 has gained much interest. 
Even more so, the estimation of a sparse inverse covariance matrix has gained more spotlight. 
This is because it involves the estimation of the inverse covariance matrix which has some 
elements equal to zero. For instance, in an 𝑛 × 𝑝 data matrix 𝑋 with independent rows which are 
distributed 𝑁(0, Σ), a zero in an off-diagonal element of Σ−1 would be due to a pair of variables 
which are conditionally independent. To this end, if we assume a multivariate Gaussian 
distribution then we can estimate a graphical model for the data using the estimation of the 
sparse inverse covariate matrix.  
In the graphical model, each node represents a feature and the edge between the 
corresponding pair of nodes represents the nonzero off-diagonal element in the inverse 
covariance matrix. Usually, Σ−1 is estimated by maximizing the log-likelihood of the data. Using 
the Gaussian model, we can represent the log-likelihood as  
 
 log det Σ−1 − 𝑡𝑟(SΣ−1) ( 3.2.2) 
 
where 𝑆 =
𝑋𝑇𝑋
𝑛
 is the estimated covariance matrix of the data. Let Θ = Σ−1. Then we can 
denote the maximum likelihood estimate of (3.2.2 ) by Θ̂ = 𝑆−1. Generally, this estimate does 
not contain any elements equal to zero. In addition, having more features than observations in 
our data, that is, 𝑝 ≫ 𝑛, will produce an 𝑆 which is singular so we would not be able to compute 
the maximum likelihood estimate.  
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Yuan and Lin [46] proposed an alternative to this, which involves maximizing the 
penalized log-likelihood over nonnegative definite matrices Θ, instead of simply maximizing the 
log-likelihood. The penalized log-likelihood is 
 
 log det Θ − 𝑡𝑟(𝑆Θ) − 𝜆‖Θ‖1 ( 3.2.3) 
 
where 𝜆 is a nonnegative tuning parameter. This problem is referred to as the graphical lasso 
(Friedman, Hastie, and Tibshirani [11]).  
There are two main advantages of using a penalized log-likelihood rather than the simple 
log-likelihood. First, regardless if 𝑆 is singular, the solution will always be positive definite for 
all 𝜆 > 0. Second, for a sufficiently large 𝜆, the estimated Θ̂ will be sparse because of the lasso-
type penalty, which has been applied to the elements of Θ (Tibshirani [41]).   
In order for the solution to the graphical lasso problem to be block diagonal with blocks 
𝐶1, 𝐶2, … , 𝐶𝐾, that is, for a set of nodes to form a connected component in the graphical model, a 
necessary and sufficient condition is required. The condition is that |𝑆𝑖𝑖′| ≤ 𝜆 for all 𝑖 ∈ 𝐶𝑘, 𝑖′ ∈
𝐶𝑘′, 𝑘 ≠ 𝑘′. This condition was discovered by Mazumder and Hastie [26] and can be 
implemented prior to solving equation (3.2.3) so that large computational gain is achieved.  
The R package for graphical lasso with version glasso1.7 uses the above condition to 
estimate a sparse inverse covariance matrix using a lasso (𝑙1) penalty. The general idea behind 
the algorithm implemented in this package is that for a specified value of the tuning parameter, if 
the solution to the graphical lasso problem will be block diagonal, then the graphical lasso 
algorithm is applied to each block separately. Using a block diagonal screening decreases 
computation time significantly.  
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The covariance matrix, 𝑆, which is a symmetric 𝑝 × 𝑝 matrix is computed from our 𝑛 × 𝑝 
data matrix 𝑋. Note that 𝑛 is the number of samples at risk of death which is 296 and 𝑝 is the 
number of genes which is 603. The glasso function is applied to the covariance matrix 𝑆 and the 
value of lambda, the regularization parameter for lasso is set equal to 0.1. A smaller value of 𝜆 is 
always preferred to a larger value of 𝜆. This is due to the fact a smaller value of 𝜆 yields less 
sparse Θ which fits the data well while a larger value of 𝜆 yields a sparser Θ which fits the data 
less well.       
The output from the glasso function includes: 𝑤 which is the estimated covariance 
matrix, 𝑤𝑖 which is the estimated inverse covariance matrix, 𝑙𝑜𝑔𝑙𝑖𝑘 which is the value of the 
maximized log-likelihood penalty, 𝑑𝑒𝑙 which is the change in the parameter value at 
convergence, 𝑛𝑖𝑡𝑒𝑟 which is the number of iterations of the outer loop used by the algorithm, 
𝑎𝑝𝑝𝑟𝑜𝑥, and 𝑒𝑟𝑟𝑓𝑙𝑎𝑔.  
Butts et al. [6] developed the network package in R, which provides a general framework 
for encoding complex relational structures composed of a vertex set along with a combination of 
edges. The tools in this package allow us to create, access, and modify network class objects 
which facilitate the representation of more complex structures from adjacency matrices. In 
addition, it also allows us to efficiently handle large sparse networks.   
Let 𝐺 denote a network, a relational structure on a given vertex set (𝑉) and an edge, such 
that 𝑇 is the “tail set” of the edge and 𝐻 is the corresponding “head set” belonging to the ordered 
pair (𝑇, 𝐻) with the property that 𝑇, 𝐻 ⊆ 𝑉(𝐺). The cardinality of the vertex set and 
corresponding edge set are denoted by |𝑉(𝐺)| = 𝑛 and |𝐸(𝐺)| = 𝑚, respectively. In an 
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undirected network, the head and tail sets of an edge are interchangeable, meaning that 𝑖 is 
adjacent to 𝑗 if there exists an edge such that 𝑖 ∈ 𝑇, 𝑗 ∈ 𝐻 or 𝑖 ∈ 𝐻, 𝑗 ∈ 𝑇.  
Using the inverse covariance matrix 𝑤𝑖 which was previously estimated using the glasso 
function, we construct our adjacency matrix. The network function uses the adjacency matrix to 
create an undirected network object. The object is plotted and a two-dimensional plot of the 
undirected network is obtained.  
 
3.3  Cox proportional hazard model with sparse group lasso penalty 
The advantage of using sparse group lasso over lasso and group lasso is that it generates a 
solution, which is both between and within group sparsity. Using the SGL package in R, which 
was developed by Simon et al. [35], we fit a cox proportional hazard model via a penalized 
maximum likelihood, which is a combination of a lasso and group lasso regularization. This 
package contains four functions, two of which we use; cvSGL and SGL. The cvSGL function is 
used to fit and cross-validate a cox model via the penalized maximum likelihood.  
The arguments specified in the function are: data, index, type, nlam, nfold, and alpha. 
The argument ‘data’ is a list which consists of an 𝑛 × 𝑝 input matrix 𝑋, an 𝑛-vector time which 
corresponds failure/censor times, and an 𝑛-vector status which indicates failure (1) or censoring 
(0). In our case, 𝑋 is a 568 × 603 matrix with gene expression levels with 𝑛 being the total 
number of samples, and 𝑝 being the number of genes selected using SCBS. The argument 
‘index’ is a 𝑝-vector which indicates group membership of each covariate. To construct the index 
vector, we use the estimated inverse covariance matrix 𝑤𝑖 generated using the glasso function 
since this was used for the estimation of the undirected network in the network function. All 
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genes belonging to the cluster (Σ𝑖𝑗
−1 ≠ 0) are assigned to group 1 and those genes not belonging 
to the cluster (Σ𝑖𝑗
−1 = 0) are each assigned a different group number. Type corresponds to the 
model type; in our case, the cox model. The argument ‘nlam’ corresponds to the number of 
lambdas to use in the regularization path which we set equal 10 and ‘nfold’ corresponds to the 
number of folds of the cross-validation loop which is set equal to 5. The mixing parameter, 𝛼, 
determines how much weight should be given to either the lasso or group lasso regression.  In 
our case, we set the mixing parameter, alpha equal to 0.95 which indicates that more weight is 
given to the lasso than the group lasso. Note that choosing a value of 𝛼 which is close to 1 
eliminates any degeneracies and problematic behavior caused by extreme correlations.  
The cvSGL function runs a total of (𝑛𝑓𝑜𝑙𝑑 + 1) times. In the first run, the sequence of 
lambda is generated. The cross-validated error rate and its standard deviation are computed in the 
consecutive runs. The output values of the cvSGL function include: lldiff which is an nlam 
vector of cross-validated log-likelihoods, llSD which is an nlam vector of approximated standard 
deviations of lldiff, lambdas which is a list of the values of lambda used in the regularization 
path, type which is the response type, and fit which is a model fit object created.  
The sparse group penalty model can be extended to other models. The two most common 
cases in which this model is implemented include logistic regression and the cox model for 
survival data. In a cox regression model, the data is a covariate matrix, 𝑋, which is divided into 
sub-matrices based on the groups, an 𝑛-vector 𝑦 which contains failure censoring times, and an 
𝑛-vector 𝛿 which indicates failure or censoring for each observation. Note that 𝛿𝑖 = 1 indicates 
that observation 𝑖 failed and 𝛿𝑖 = 0 indicates the observation 𝑖 was censored. Under this model, 
the sparse group lasso is expressed by 
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𝛽 = arg min
𝛽
1
𝑛
[log (∑ (∑ exp(𝑥𝑗
𝑇𝛽) − 𝑥𝑖
𝑇𝛽
𝑗∈𝑅𝑖
)
𝑖∈𝐷
)] + (1 − 𝛼)𝜆 ∑ √𝑝𝑙‖𝛽
(𝑙)‖ + 𝛼𝜆‖𝛽‖1
𝑚
𝑙=1
 ( 3.3.1) 
 
where 𝐷 is the set of failure indices, and 𝑅𝑖 is the set of indices, 𝑗, such that we have 𝑦𝑗 ≥ 𝑦𝑖 
which denotes those patients still at risk at failure time 𝑖. 
 
3.4  Kaplan-Meier Curves  
In 1958, Edward L. Kaplan and Paul Meier developed a way of dealing with incomplete 
observations and as a result, Kaplan-Meier curves and estimates of survival data have become 
useful in dealing with differing survival times such as times-to-event in which some of the 
subjects do not continue in the study. Time-to-event can be defined as a clinical duration variable 
for each subject in the study. It may begin at the point in time when the subject becomes a part of 
a study or when the subject begins receiving treatement and ends when the subject reaches the 
event of interest or is censored from the study.  
Kaplan-Meier survival analysis requires three variables for each of the subjects in the 
study. These variables include the survival time (time-to-death), their status at the end of the 
study (event occurrence or censored), and the group they belong to. Censoring occurs when the 
total survival time for a subject cannot be correctly determined due to reasons such as the subject 
dropping out from the study or the subject survives until the end of the study (Rich et al. [30]).  
 The Kaplan-Meier estimate is the simplest way of estimating a population survival curve 
from a sample as it allows us to compute the survival over time regardless of the difficulties 
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associated with subjects or situations. In estimating the survival curve, we compute the 
probabilities of the occurrence of an event at a certain point of time and multiply these 
successive probabilities by any previously computed probabilities to get the final estimate. The 
Kaplan-Meier estimator of the survival function at time 𝑡 is  
 
 𝑆
 (𝑡) = ∏
𝑛𝑖 − 𝑑𝑖
𝑛𝑖
𝑡(𝑖)≤𝑡
 ( 3.4.1) 
 
where 𝑛𝑖 denotes the number at risk of dying at 𝑡(𝑖) and 𝑑𝑖 denotes the observed number of 
deaths. Note that  𝑆 (𝑡) = 1 if 𝑡 < 𝑡(1). The survival probability is calculated by dividing the 
number of subjects surviving by the number of patients at risk. Subjects at risk do not include 
subjects who have died, dropped out of the study, or have been censored (Goel et al. [18]).  
The cox proportional hazard model is useful in identifying variables, which may be of 
prognostic importance. In theory, the number of variables which can be included in the cox 
model are infinite. For a regression model with 𝑘-variables, the hazard function is  
 
 ℎ(𝑡, 𝑥1, 𝑥2, … , 𝑥𝑘 , 𝛽) = ℎ0(𝑡) exp(𝛽0 + 𝛽1𝑥1 + 𝛽2𝑥2 + ⋯ + 𝛽𝑘𝑥𝑘) ( 3.4.2) 
 
where ℎ0(𝑡) is the baseline hazard function, 𝛽0 is the intercept, and 𝛽1, 𝛽2 , … , 𝛽𝑘 are the 
corresponding regression coefficients estimated in the modelling process. 
 
 
 
19 
 
We can express the above equation as a log-hazard function in the form 
 
 ln [
ℎ(𝑡, 𝑥1, 𝑥2, … , 𝑥𝑘 , 𝛽)
ℎ0(𝑡)
] = 𝛽0 + 𝛽1𝑥1 + 𝛽2𝑥2 + ⋯ + 𝛽𝑘𝑥𝑘 ( 3.4.3) 
 
Although it is possible to include an infinite number of variables in the model, there are 
practical constraints in the estimation of the regression coefficients. For this reason, the number 
of variables included in the model cannot be greater than the number of events available for the 
analysis.  
To calculate the confidence interval (CI), 𝑆 (𝑡) is transformed using a scale which 
approximately follows a Normal distribution. This is commonly achieved using a logarithmic 
transformation of 𝑆 (𝑡). Using this transformed scale, the endpoints of a 100(1 − 𝛼) percent 
confidence interval for the log-log survival function are given by the expression 
 
 
ln [− ln (𝑆 (𝑡))] ± 𝑧1−𝛼/2𝑆?̂? {ln [− ln (𝑆 (𝑡))]} 
( 3.4.5) 
 
where 𝑧1−𝛼/2 is the upper 𝛼/2 percentile of the standard normal distribution.  
Taking the antilog of the lower and upper values of the CI in (3.4.5) allows us to return to 
the untransformed scale. The lower and upper endpoints of the confidence interval for the 
survival function are, respectively 
 
 exp[− exp( ?̂?𝑢 )]    and    exp[− exp( ?̂?𝑙 )] ( 3.4.6) 
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Note that since 𝑆 (𝑡) always has values ranging from 0 to 1, the CI computed with (3.4.6) will 
always be in the range of 0 to 1.   
When interpreting K-M curves, we look for gaps in these curves in a horizontal or 
vertical direction. A horizontal gap indicates that a particular group took longer to experience a 
certain fraction of deaths. A vertical gap indicates that at a specific point in time, a particular 
group had a greater fraction of subjects surviving. The Kaplan-Meier survival analysis is a 
convenient method of estimating survival times as it allows us to use the information from 
subjects who are censored up to the time when they are censored (Machin et al. [24]).  
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4.  RESULTS AND DISCUSSION  
4.1  Results  
Using the ‘data matrix’ tool available in TGCA data portal, the data was extracted. This 
data set contains the expression values of 17,814 genes. Table 4.1.1 presents a summary of 
TCGA ovarian cancer data, which includes the data types we incorporated in the analysis and the 
number of available cases for each data type.  
 
Data type Platform Cases 
Gene expression Agilent G4502A_07 583 
Clinical information N/A 585 
Table 4.1.1. Summary of TCGA ovarian cancer data. 
 
Using the stepwise correlation-based selector (SCBS) approach for feature selection, a 
subset of 603 genes was selected from the total 17,814 genes. The sparse inverse covariance 
matrix was estimated using the blockwise coordinate descent algorithm for penalized maximum 
likelihood estimation which is employed in the glasso package in R. The undirected network was 
constructed using the network package in R. The predicted network contains 589 nodes within 
the cluster and the remaining 14 nodes are not connected.  
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Figure 4.1.1. Undirected network generated using the graphical lasso algorithm with a 
regularization parameter 𝛌 = 𝟎. 𝟏. 
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 We applied the cox proportional hazard model with sparse group lasso penalty to fit a 
survival model to our data. The 603 gene expression levels for all 568 samples along with the 
clinical information for these samples were fed into the sparse group lasso (SGL) algorithm 
which is implemented in R. The survival time is given in days and it is defined as the time 
between diagnosis and death. The death risk (status) is treated as a binary variable which 
represent failure as 1 and censoring as 0. The index for all 603 genes contains the group 
membership of genes. The 589 genes which are in the same cluster are assigned to group 1 and 
the remaining 14 genes which do not belong to the cluster are each assigned to a different group 
from group 2 to group 15.  
A cox proportional hazard model is fit to the data using 10 lambdas in the regularization 
path and 5 folds for the cross-validation loop. Using the log-likelihoods along with the lambda 
values used in the regularization path from the output, we construct a plot.  
 
Number Lambda Log likelihood 
1 0.003507721 2149.039 
2 0.002514584 2220.560 
3 0.001802633 2362.001 
4 0.001292256 2613.528 
5 0.000926381 3013.686 
6 0.000664096 3694.887 
7 0.000476071 4995.810 
8 0.000341282 8315.698 
9 0.000244655 14627.111 
10 0.000175386 25431.210 
Table 4.1.2. Lambda values with their corresponding log-likelihood computed by cv.SGL.   
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Figure 4.1.2. Plot of the log-likelihoods against their corresponding lambda values. 
 
 A common method for selecting the tuning parameter 𝜆 is to use cross-validation to select 
the optimal 𝜆 (Sun et al. [39]; Wasserman and Roeder [42]; Sofer et al. [37]). The problem with 
using the cross-validation method is that it yields large number of false positives in the sparse 
network problem (Fu and Zhou [14]). A method which has shown to be more effective in 
indentifying the optimal 𝜆 is the “change point” method. The “change point” method uses the 
change in the log likelihood for different values of 𝜆. Based on this method, the optimal 𝜆 
corresponds to the change point at which increasing 𝜆 does not yield a significant decrease in the 
log likelihood value. The optimal lambda selected is lambda 7 with a value of 𝜆=0.000476071. 
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 Using the optimal 𝜆 that was selected, we fit a cox proportional hazard model with a 
combination of lasso and group lasso regularization. The input matrix, survival time, status and 
index all remain the same as what was used in the cv.SGL function. The difference in using the 
SGL function is that the optimal 𝜆, lambda 7, is used in fitting the cox model to the data. The 
mixing parameter, 𝛼, is set equal to 0.95. The beta cofficients for all 603 genes were estimated 
using the cox model in the SGL function. After fitting the regression model to the data, those 
genes for which the null hypothesis (𝐻0: 𝛽𝑖 = 0) is rejected, are kept in the model and are 
termed prognostic. The remaining genes which are not statistically different from zero are 
removed from the model and are not considered prognostic for the outcome.  
 The total number of genes with nonzero beta coefficients is 232 genes. Using the gene 
expression level for these 232 genes along with their estimated beta coefficients, we will 
compute the survival rate for all 568 samples. The survival estimates are computed by  
 
 𝑆𝑖 = 𝛽0 + 𝛽1𝑔1𝑖 + 𝛽2𝑔2𝑖 + ⋯ + 𝛽232𝑔232𝑖 ( 4.1.1) 
 
where 𝛽1, 𝛽2 , … , 𝛽232 are the corresponding regression coefficients estimated in the modelling 
process and 𝑖 is the index for the sample where 𝑖 = 1, 2, … , 568. 
After computing these survival estimates, we will sort these estimates in ascending order. 
We evenly divide the survival estimates into 2 groups where group 1 includes the first 284 
estimates and group 2 includes the remaining 284 estimates. Similarly, we divide the survival 
estimates into 3 groups while sorted in ascending order. The survival package in R allows us to 
construct survival curves from a fitted cox model using the survfit function. Kaplan-Meier curves 
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will be plotted using the survival time and status for the 2 groups (low risk and high risk). The 
procedure is also repeated for the case of 3 groups (low risk, medium risk, and high risk). 
 
 
Figure 4.1.3. Kaplan-Meier curves with 95% confidence intervals for low and high-risk groups. 
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Figure 4.1.4. Kaplan-Meier curves with 95% confidence intervals for low, medium, and high-
risk groups. 
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4.2  Discussion 
The K-M estimates of the survival curves are given by the graph of 𝑆(𝑡) against time in 
days in figures 4.1.3 and 4.1.4. 𝑆(𝑡) begins at 1, where all patients in the study are alive, since 
𝑆(0) = 1 and then progressively decline towards 0 where all patients have died with time. Since 
the estimated survival curve remains at a plateau between successive patient death times, the 
graph of 𝑆(𝑡) is plotted as a step function. At each time of death, there is an instantaneous drop 
to a new level. The graph only attains a value of 0 if the patient with the longest observed 
survival time dies. In the event that the patient is still alive, the K-M curve has a plateau which 
begins at the time of the last death and continues until the censored survival time of this longest 
surviving patient. The censored survival times are marked on the curve with bold vertical lines 
cutting the curve.  
 Since we are estimating the difference between 2 groups and 3 groups depending on the 
potential risk, it is useful to calculate confidence intervals (CI) for the estimates. The survival 
estimates were partitioned into 2 and 3 groups based on low risk and high risk and low risk, 
medium risk, and high risk, respectively. The corresponding survival curves were estimated 
using the samples that fall into these groups. As a measure of the reliability of the estimates at 
key points along the K-M survival curves, we computed the 95% CI for 𝑆(𝑡) at time 𝑡.  
The survival curves show a better outcome for low risk patients than the high risk 
patients in figure 4.1.3. As expected, the survival curves indicate a gradient of survival 
differences between the two groups. Since the K-M curves for the different risk groups are 
adequately separated, these groups can be used for prognosis. It can be noted from figure 4.1.4 
that even though there is a clear difference between low, medium, and high risk groups, the 
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separation between the three groups is not as pronounced as that of figure 4.1.3. For instance, the 
medium and high risk groups have ‘shrunk’ closer to each other while the low risk group appears 
to have a relatively similar prognosis.   
From the 232 genes which were termed prognostic for ovarian cancer survival, we found 
10 of those genes which are directly related to cancer. Protein ubiquitination (CCNB1IP1) is 
important for many cellular processes as it is able to regulate protein degradation and signal 
mechanisms. Alterations of the ubiquitination mechanism have become evident in human 
cancers. Levels of UB ligases have been found to be significantly correlated with relevant 
prognostic factors as well as with the clinical outcome (Confalonieri et al. [7]). CDK5RAP2 is 
necessary for spindle checkpoint function (Zhang et al. [51]). The expression of COL2A1 has 
also shown useful in predicting tumor recurrence in high-grade serous ovarian cancer (Ganapathi 
et al. [16]). COL8A1 in hepatocarcinoma cells has shown to be correlated with increased tumor 
cell proliferation (Ma et al. [23]). Over-expression of EIF6 has shown to increase the motility 
and invasiveness of cancer cells by controlling the expression of a critical subset of membrane-
bound proteins (Pinzaglia et al. [28]). GATA6 promotes colon cancer cell invasion through the 
regulation of urokinase plasminogen activator (uPA) gene expression. It contributes to colorectal 
tumorigenesis and tumor invasion (Belaguli et al. [4]). Splice variants (SVs) of receptors for the 
growth hormone-releasing hormone (GHRH) have been detected in several human cancers and 
cancer cell lines. Antagonists of GHRH have shown to inhibit growth of various human cancers 
(Garcia-Fernandez et al. [15]). The expression of interferon regulatory factor-1 (IRF-1) is a 
nuclear transcription factor which mediates interferon and other cytokine effects. IRF-1 appears 
to have antitumor activity in vitro and in vivo in cancer cells (Kim et al. [20]). The expression 
NLRX1 acts as a potential tumor suppressor through the regulation of the TNF-α induced 
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apoptosis (cell death) and metabolism in cancer cells (Singh et al. [36]). The expression level of 
presenilin 1 (PSEN1) has shown to be negatively correlated with chemoresistance. A minor 
interference of the RNA mediated repression in the PSEN1 gene has shown to suppress cell 
apoptosis, the multi-chemoresistance of bladder cancer (Deng et al. [10]). 
 
Gene 
Symbol 
Gene Name Resource 
CCNB1IP1 
Cyclin B1 Interacting 
Protein 1 , E3 Ubiquitin 
Protein Ligase 
http://www.ncbi.nlm.nih.gov/pubmed/19543318 
CDK5RAP2 
CDK5 Regulatory 
Subunit Associated 
Protein 2 
http://www.ncbi.nlm.nih.gov/pubmed/19282672 
COL2A1 
Collagen, Type II, Alpha 
1 
http://www.ncbi.nlm.nih.gov/pubmed/26311224 
COL8A1 
Collagen, Type VIII, 
Alpha 1 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3
501407 
EIF6 
Eukaryotic Translation 
Initiation Factor 6 
http://bmccancer.biomedcentral.com/articles/10.1
186/s12885-015-1106-3 
GATA6 GATA Binding Protein 6 http://www.ncbi.nlm.nih.gov/pubmed/21076612 
GHRH 
Growth Hormone 
Releasing Hormone 
http://www.ncbi.nlm.nih.gov/pubmed/12602901 
IRF1 
Interferon Regulatory 
Factor 1 
http://www.nature.com/onc/journal/v23/n5/full/1
207023a.html 
NLRX1 NLR Family Member X1 http://www.ncbi.nlm.nih.gov/pubmed/25639646 
PSEN1 Presenilin 1 http://www.ncbi.nlm.nih.gov/pubmed/25542424 
Table 4.2.1. Ten cancer-related genes, which were found to be prognostic for ovarian cancer 
survival, based on the cox proportional hazard model with sparse group lasso penalty.  
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Gene Symbol Function 
CCNB1IP1 Functions in progression of the cell cycle through G(2)/M 
CDK5RAP2 Potential regulator of CDK5 activity via its interaction with CDK5R1 
COL2A1 Essential for the normal embryonic development of the skeleton, for linear 
growth and for the ability of cartilage to resist compressive forces 
COL8A1 Necessary for migration and proliferation of vascular smooth muscle cells 
and thus, has a potential role in the maintenance of vessel wall integrity and 
structure 
EIF6 Binds to the 60S ribosomal subunit and prevents its association with the 40S 
ribosomal subunit to form the 80S initiation complex in the cytoplasm. 
GATA6 Transcriptional activator that regulates SEMA3C and PLXNA2 
GHRH essential for normal expansion of the somatotrope lineage during pituitary 
development 
IRF1 Plays roles in the immune response, regulating apoptosis, DNA damage and 
tumor suppression 
NLRX1 Participates in antiviral signaling. Acts as a negative regulator of MAVS-
mediated antiviral responses, through the inhibition of the virus-induced 
RLH (RIG-like helicase)-MAVS interaction 
PSEN1 Plays a role in intracellular signaling and gene expression or in linking 
chromatin to the nuclear membrane 
Table 4.2.1. Functions of the ten cancer-related genes, which were found to be prognostic for 
ovarian cancer survival, based on the cox proportional hazard model with sparse group lasso 
penalty. 
 
  Based on the presence of these ten cancer-related genes in our cox proportional hazard 
model for cancer survival, we have shown that ovarian cancer shares common genes with other 
cancer types due to the pathological similarity. These findings suggest that certain genes could 
play essential and common roles across different cancer types.  
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5.  CONCLUSIONS 
5.1  Summary 
The stepwise correlation-based selector was used in selecting relevant genes for ovarian 
cancer survival. Out of the 17,814 genes, a subset of 603 genes was selected using SCBS. These 
603 genes were then used to estimate the sparse inverse covariance matrix through the graphical 
lasso algorithm and an undirected network of these genes was constructed. Genes belonging to 
the same cluster were assigned to the same group and genes outside of the cluster were each 
assigned a different group number. A cox proportional hazard model with sparse group lasso 
penalty was fit to our data. The model determined 232 genes which are prognostic in cancer 
survival. Survival estimates were calculated using the gene expression levels and the estimated 
beta coefficients for these 232 genes. Based on these estimates, we divided the samples into 2 
and 3 groups based on low risk, medium risk, and high risk. The K-M curves for the different 
risk groups were adequately separated which may suggest that these groups can be used for 
prognosis. Of these 232 genes, many were reported to be associated with cancer initiation or 
progression in the literature. Based on these findings it appears that certain genes share common 
roles across different types of cancer.   
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5.2  Future Work 
In this paper, we considered gene expression levels as prognostic biomarkers in ovarian 
cancer survival. Although the results presented here have demonstrated the effectiveness of 
identifying biomarkers important in cancer survival, it could be further developed in a number of 
ways. Future extensions to this research could include: incorporation of more genomic profiles, 
use of Bayesian network modeling, extension of the graphical lasso model for nonparanormal 
distribution, use of cross-validation to select an optimal value for the mixing parameter (𝛼), and 
using a smaller value for the regularization parameter, 𝜆, along with community detection to 
partition the network structure into more clusters.   
Carcinogenesis involves multi-level dysregulations, which include genomics, DNA 
methylomics, and transcriptomics (An et al. [1]). With recent advances in rapid high-throughput 
genetic and genomic analysis, we are now able to identify a plethora of alterations which can 
possibly serve as new cancer biomarkers. Each distinct data type such as copy number variations, 
gene and microRNAs expression, CpG island methylation provides us with a different, 
somewhat independent, and complementary view of the entire genome (Sokolova et al. [38]). To 
understand a gene function, it is necessary to analyze more than one single type of data. For us to 
be able to uncover the intricate underlying mechanisms, we must go beyond simply 
understanding one molecular level of cancer.  
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Data type Platform Cases 
Gene expression Agilent 244K 583 (8 organ-specific controls) 
Somatic mutation Agilent 415K 587 (8 organ-specific controls) 
DNA methylation Illumina 27K 592 (8 organ-specific controls)  
Copy number variation Agilent 1M 587 (8 organ-specific controls) 
Clinical information N/A 585 
Table 5.2.1. Summary of TCGA ovarian cancer data including data types, platform, and the 
number of available cases. 
 
Bayesian network (BN) is a probabilistic model consisting of a directed acyclic graph 
(DAG) and an underlying joint probability distribution which uses the prior probability in the 
prediction of dependent variables. With the use of Bayesian network, we are able to model a 
multidimensional probability distribution in a sparse way while at the same time searching for 
independency relations in the data. Compared to the undirected network model, directed 
networks models such as the Bayesian network are more informative since we are able to 
visualize the influences and relations of genes as well as describe hidden dependencies among 
genes. Bayesian network is of great interest in bioinformatics since the probabilistic inference 
provides a passage for clinical decision making through the intuitive encapsulation of causal 
links, which exist between diagnostic and prognostic factors (Gevaert et al. [17]; Sesen et al. 
[32]).  
The Gaussian graphical model is the standard parametric model used for continuous data; 
however, its distributional assumptions are generally unrealistic. For real-valued data in high-
dimensional situations, the estimation of sparse undirected graphs relies heavily of the 
assumption of normality. Assuming normality is not always realistic, especially in a practical 
setting. Both the nonparanormal and Gaussian graphical models can be used in graph estimation 
and construction; however, they yield different graphs over a wide range of regularization 
parameters, which suggests the possibility of having different biological conclusions (Lafferty et 
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al. [21]). Fitting a high-dimensional nonparanormal model can also be achieved using the 
graphical lasso approach and is no more computationally difficult than estimating a multivariate 
Gaussian model.  
Cross-validation is often performed to aid in model selection through the choice of an 
optimal value of a penalty parameter. To select the optimal parameter value, a 10-fold cross-
validation (CV) is commonly used. The optimal parameter value is that value for which the 10-
fold cross-validated penalized (partial) log-likelihood deviance of the model is minimal (Sill et 
al. [33]). In this research, the change point method was used to select the optimal value of the 
regularization parameter, 𝜆; however, the mixing parameter 𝛼 was set to 0.95. Since we want to 
achieve both sparsity between and within groups, using cross-validation to select an optimal 
value of the mixing parameter 𝛼 will be more useful (Ritter [31]).  
Community structure is the division of networks into communities (clusters), which are 
densely connected among their members, and sparsely connected with the rest of the network 
(Pizzuti [29]). It is an interesting property to investigate as it can reveal abundant hidden 
information about complex networks, which cannot be not easily detected by simple observation 
(Liu et al. [22]). One of the main problems in network and data sciences is community detection 
(Abbe [1]). Detecting communities within a network can provide useful insights on the general 
structure of the network so that we may further understand specific gene functions in these 
complex biological networks. Common algorithms used for community detection include 
Infomap, LPA, Fastgreedy and Walktrap. In this research, using a smaller value for the 
regularization parameter, 𝜆, would yield a network with more clusters. We could then use a 
community detection algorithm to detect communities within the undirected network based on 
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similar characteristics and gene functions. This would allow us to have more groups when fitting 
a cox proportional hazard model with a sparse group lasso penalty.  
There is still a lot more work to be done before we can fully understand the prognostic 
biomarkers in ovarian cancer survival. Employing different network models, relaxing the 
normality assumption, using cross-validation to select an optimal value for the mixing parameter 
(𝛼), as well as using a smaller value for the regularization parameter, 𝜆, to partition the network 
structure into more clusters, along with community detection in the analysis of different genomic 
profiles could potentially lead to the identification of new biomarkers.  
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